Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study

BACKGROUND: A recent study has shown that treatment of visceral leishmaniasis (VL) with the standard dose of 15 mg/kg/day of paromomycin sulphate (PM) for 21 days was not efficacious in patients in Sudan. We therefore decided to test the efficacy of paramomycin for a longer treatment duration (15 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Musa, Ahmed M., Younis, Brima, Fadlalla, Ahmed, Royce, Catherine, Balasegaram, Manica, Wasunna, Monique, Hailu, Asrat, Edwards, Tansy, Omollo, Raymond, Mudawi, Mahmoud, Kokwaro, Gilbert, El-Hassan, Ahmed, Khalil, Eltahir
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964291/
https://www.ncbi.nlm.nih.gov/pubmed/21049063
http://dx.doi.org/10.1371/journal.pntd.0000855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964291/
https://www.ncbi.nlm.nih.gov/pubmed/21049063
http://dx.doi.org/10.1371/journal.pntd.0000855

Ejemplares similares